Chinas Seven Titans Tech Stocks Decline as Deflation Concerns Eclipse AI Optimism SpaceX and OpenAI MegaIPOs Raise Market Top Concerns Among Analysts The HighStakes Business of Orchid Breeding A DecadeLong Investment with Lucrative Potential The AI Economy Reshapes Opportunity BlueCollar Trades Gain Favor as WhiteCollar Entry Roles Slow Rosenblatt Adjusts Price Target for Cisco Systems Potential Upside Ahead Fed Rate Cut Prospects Diminish as April Jobs Report Signals Labor Market Stability FTRE Q1 2026 Earnings Significant EPS Beat Driven by Operational Improvements GOTU Q4 2025 Earnings EPS Beats Estimates Stock Declines Amid Ongoing Challenges CRAI Q1 2026 Earnings EPS Misses Estimates as Consulting Demand Softens Nutrien Ltd NTR Q1 2026 Earnings EPS Misses Estimates by 473 Amid Challenging Market Conditions SCHL Q1 2026 Earnings EPS Beats Estimates as Scholastic Posts SmallerThanExpected Loss Satellogic Q1 2026 Earnings Significant EPS Miss Overshadowed by Stock Rally Fortress Biotech Preferred FBIOP Gains 121 as Income Seekers Eye 9375 Yield Performance Shipping Inc PSHG Faces Continued Pressure Testing Key Support Levels Mamas Creations Inc MAMA Edges Higher as Stock Consolidates Near Key Levels Venu Holding Corporation VENU Edges Lower as Key Support Levels Are Tested Pharming Group Slips to 1260 as Key Support Levels Come Into Focus LYB Q1 2026 Earnings EPS Surges 140 Above Estimates Amid Improved Operations EVH Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction Amidst Disciplined Cost Management VTSI Q1 2026 Earnings EPS Surprises Slightly Above Estimates Despite Stock Decline FN Q1 2026 Earnings EPS Beat Amid Steady Operational Performance GBank Financial Holdings Inc GBFH Q1 2026 Earnings Significant EPS Miss as Earnings Fall Short of Expectations CPAY Q1 2026 Earnings EPS Beats Estimates Amid Strong Operational Performance SGX RegCo Proposes ThreeYear Suspension Limit for Listed Firms to Enhance Market Certainty PRLD Q1 2026 Earnings Narrower Loss Than Anticipated as Clinical Pipeline Advances Polaryx Therapeutics PLYX Slides 86 as Stock Tests Key Support Levels